Acadia Healthcare (ACHC) slides as Q2 profit outlook and startup losses outweigh Q1 beat and raised full-year targets

Acadia Healthcare Company, Inc. (ACHC) is down 10.2% today. Here is some analysis on what might have caused this price movement.

Analysis: The selloff appears tied to investors focusing on Acadia’s second-quarter profit outlook and near-term margin headwinds, even as the company posted year-over-year revenue growth and raised full-year adjusted guidance. Management also flagged startup losses and higher bad debts/denials as offsets, which likely reinforced concerns that earnings power remains pressured in the near term.

Details:

Acadia reported Q1 2026 revenue of $828.8 million (up 7.6% year-over-year), but GAAP profitability was slim (net income attributable to Acadia of about $4.1 million, or $0.05 per diluted share) versus adjusted EPS of $0.37.

The company issued Q2 2026 guidance of revenue $835–$850 million and adjusted EPS $0.30–$0.40, a range that can imply a step-down versus the just-reported quarter’s adjusted earnings.

Q2 guidance assumptions included approximately $15 million of startup losses and no incremental new supplemental payments.

Results also showed rising financing and certain operating costs, including higher interest expense year-over-year and a larger legal settlements expense line item versus the prior-year quarter.

Sources:

SEC, Acadia Healthcare (Investors), Investing.com

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

EARLY ACCESS

Receive ACHC Data Alerts

Real-time alerts on filings, insider trades, and market signals — before everyone else.

Get Alerts →

$ACHC Hedge Fund Activity

We have seen 146 institutional investors add shares of $ACHC stock to their portfolio, and 160 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

SACHEM HEAD CAPITAL MANAGEMENT LP removed 4,215,000 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $59,810,850
JEFFERIES FINANCIAL GROUP INC. added 3,379,813 shares (+inf%) to their portfolio in Q4 2025, for an estimated $47,959,546
DEERFIELD MANAGEMENT COMPANY, L.P. added 3,331,000 shares (+280.2%) to their portfolio in Q4 2025, for an estimated $47,266,890
DME CAPITAL MANAGEMENT, LP added 2,478,493 shares (+150.9%) to their portfolio in Q4 2025, for an estimated $35,169,815
UBS GROUP AG removed 2,358,607 shares (-54.4%) from their portfolio in Q4 2025, for an estimated $33,468,633
WELLINGTON MANAGEMENT GROUP LLP added 2,350,760 shares (+24.9%) to their portfolio in Q4 2025, for an estimated $33,357,284
P2 CAPITAL PARTNERS, LLC removed 2,337,188 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $33,164,697

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API.

$ACHC Analyst Ratings

Wall Street analysts have issued reports on $ACHC in the last several months. We have seen 4 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

Keybanc issued a "Overweight" rating on 11/18/2025
RBC Capital issued a "Outperform" rating on 11/12/2025
Guggenheim issued a "Buy" rating on 11/10/2025
UBS issued a "Buy" rating on 11/07/2025

To track analyst ratings and price targets for $ACHC, check out Quiver Quantitative's $ACHC forecast page.

$ACHC Price Targets

Multiple analysts have issued price targets for $ACHC recently. We have seen 13 analysts offer price targets for $ACHC in the last 6 months, with a median target of $22.0.

Here are some recent targets:

Ryan Langston from TD Cowen set a target price of $30.0 on 04/28/2026
A.J. Rice from UBS set a target price of $31.0 on 04/17/2026
Andrew Mok from Barclays set a target price of $20.0 on 03/03/2026
Ben Hendrix from RBC Capital set a target price of $28.0 on 02/26/2026
Whit Mayo from Leerink Partners set a target price of $22.0 on 02/26/2026
Jason Cassorla from Guggenheim set a target price of $22.0 on 02/23/2026
Brian Tanquilut from Jefferies set a target price of $15.0 on 01/22/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.